Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2010
02/04/2010US20100028422 Pharmaceutical Compositions and Methods for Treating or Preventing Oxalate-Related Disease
02/04/2010US20100028421 Solid Oral Dosage Form Containing an Enhancer
02/04/2010US20100028420 Controlled release composition and process
02/04/2010US20100028419 Membrane(s) and uses thereof
02/04/2010US20100028418 Gainac specific binding molecules and uses thereof
02/04/2010US20100028417 Use of substituted glycerin derivatives for producing a pharmaceutical preparation
02/04/2010US20100028416 Drug carriers
02/04/2010US20100028415 Method of Inducing Neutralizing Antibodies to Human Immunodeficiency Virus
02/04/2010US20100028414 Combination of tyrosine kinase inhibitor and her-2/neu for cancer therapy
02/04/2010US20100028413 Skin treatment strip
02/04/2010US20100028412 Transdermal therapeutic system for administering water-soluable active ingredients
02/04/2010US20100028411 Adhesive skin patch and method for evaluation of adhesive skin patch
02/04/2010US20100028410 Immunogenic compositions and methods of use
02/04/2010US20100028409 Barrier Membranes For Guided Bone Regeneration
02/04/2010US20100028408 Method for sterilizing unheated raw honey, a honey-based wound care preparation, a wound care treatment product, and a biscuit based on honey
02/04/2010US20100028407 Layered bio-adhesive compositions and uses thereof
02/04/2010US20100028406 Topical drug delivery by iontophoresis
02/04/2010US20100028405 Matrix, cell implantation and method for their production and use
02/04/2010US20100028404 Compound and device for treating bone and/or cartilage defects
02/04/2010US20100028402 Nanoparticle-based anticoagulant
02/04/2010US20100028400 Pharmaceutical composition on the basis of stachytarpheta sp., a process for obtaining the same and its use for treating vitiligo
02/04/2010US20100028399 Use of Polymers
02/04/2010US20100028395 Compositions containing n-acetylglucosamine for use in dermo-cosmetology and aesthetic medicine
02/04/2010US20100028390 Transdermal Delivery Device
02/04/2010US20100028389 Controlled release dosage form for pain relief; continuously release-rate controlled doses
02/04/2010US20100028388 System and method for transdermal drug delivery
02/04/2010US20100028387 Biocompatible Coated Nanostructured Titanium Surfaces
02/04/2010US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity
02/04/2010US20100028273 Methods and kits for cleaning and remineralizing teeth
02/04/2010US20100028269 Dry powder formulations
02/04/2010US20100028268 Compositions and Methods For Treating Infectious Bronchitis
02/04/2010US20100028267 Compositions and methods for reducing capillary permeability
02/04/2010US20100028266 Composition and methods for treating allergic response
02/04/2010US20100028260 Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
02/04/2010US20100026235 Charging Control in an Electric Vehicle
02/04/2010DE19681438B4 Verwendung von Polypeptidanaloga mit erhöhter Elektrotransportierbarkeit und Parathormon (PTH) - Analog Use of polypeptide analogs with increased Elektrotransportierbarkeit and parathyroid hormone (PTH) - Analog
02/04/2010DE102008035834A1 Verfahren zur Herstellung von Liposomkomplexen mit unterschiedlichen Wirkstoffen und damit hergestellte Produkte, insbesondere kosmetische Produkte A process for preparing Liposomkomplexen with different active ingredients and thus prepared products, in particular cosmetic products
02/04/2010DE102008034098A1 Zubereitung und lontophoretische Vorrichtung für die transdermale Anwendung von Wirkstoffen Preparation and iontophoretic device for transdermal application of active substances
02/04/2010CA2732655A1 Microencapsulate and process for the manufacture thereof
02/04/2010CA2732635A1 Curcumin nanoparticles and methods of producing the same
02/04/2010CA2732585A1 Formulations containing large-size carrier particles for dry powder inhalation aerosols
02/04/2010CA2732509A1 Thermochemical ablation system using heat from delivery of electrophiles
02/04/2010CA2732368A1 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
02/04/2010CA2732252A1 Particle compositions with a pre-selected cell internalization mode
02/04/2010CA2732243A1 Pharmaceutical composition
02/04/2010CA2732224A1 Sleeve for transdermal patches
02/04/2010CA2731449A1 Microparticulate oral drug form useful for the modified release of nanoparticles
02/04/2010CA2731173A1 Nanoparticle compositions for nucleic acids delivery system
02/04/2010CA2730441A1 Delivery particle
02/04/2010CA2718750A1 Preparation method of biodegradable micro-particles containing drugs
02/04/2010CA2674116A1 Solid film, rapidly dissolvable in liquids
02/03/2010EP2149376A1 Body-temperature lowering depressant
02/03/2010EP2149370A1 Diazabicyclic compounds and microemulsions thereof
02/03/2010EP2149369A1 Instant oral formulations, gelling at room temperature, useful to treat physical wasting and the depressive syndrome associated with cachexia, anorexia, metabolic disorders, endocrine disorders and dysphagia
02/03/2010EP2148708A1 Composition for enhancing bone formation
02/03/2010EP2148701A2 Imaging contrast agents using nanoparticles
02/03/2010EP2148675A1 Anti-cancer medicine both for diagnosing and treating cancer
02/03/2010EP2148663A2 Pulmonary delivery of spherical insulin microparticles
02/03/2010EP2148662A1 Ultrasound imaging with targeted microbubbles
02/03/2010EP2148661A1 Oral controlled release compositions comprising vitamin d compound and waxy carrier
02/03/2010EP2148660A2 Sustained release
02/03/2010EP2148659A2 Low-dose doxepin formulations
02/03/2010EP2148657A2 Process for obtaining steroidal phosphate compounds
02/03/2010EP2148656A2 Stabilised pharmaceutical composition containing pregabaline
02/03/2010EP2148655A2 Pharmaceutical compositions of clopidogrel
02/03/2010EP1742729B8 Process for production of ionically crosslinked polysaccharide microspheres
02/03/2010EP1078636B1 Pharmaceutical composition for use in emergency treatment and preparation method thereof
02/03/2010CN101641087A Vegetarian microcapsules
02/03/2010CN101641086A Polypeptide films and methods
02/03/2010CN101641085A A tablet having improved stability with at least two actives
02/03/2010CN101641084A Pharmaceutical composition
02/03/2010CN101641083A Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers
02/03/2010CN101637463A Method for preparing borneol-modified galanthamine soft liposome cataplasm
02/03/2010CN101637462A Compositions for conjugated estrogens and associated methods
02/03/2010CN101637461A Moguisteine dispersible tablet and preparation method thereof
02/03/2010CN101637460A Glucosamine sulfate tablet and preparation method thereof
02/03/2010CN101637459A Aluminum-magnesium dimeticone chewable tablet and preparation method thereof
02/03/2010CN101637458A Preparation method of stable decitabine freeze-dried preparation
02/03/2010CN101637457A Preparation method for cerebroprotein hydrolysate freeze-dried injection for injection
02/03/2010CN101637456A Suspension powder injection of cefamandole nafate and new application thereof
02/03/2010CN101637455A Eptifibatide powder injection
02/03/2010CN101637454A Recombinant human bone morphogenetic protein-2 chitosan microballon and preparation method thereof
02/03/2010CN101637453A Method for preparing amifostine microspheres
02/03/2010CN101637452A Atorvastatin calcium dried suspension and preparation method thereof
02/03/2010CN101637451A Lomoxicam liposome medical composition and solid formulation thereof
02/03/2010CN101637450A Levocarnitine liposomes injection
02/03/2010CN101637449A Nanometer vitamin self-microemulsion and preparation method thereof
02/03/2010CN101637448A Isosorbide mononitrate liquid preparation and preparing method thereof
02/03/2010CN101637447A Sitafloxacin hydrate injection and preparation method thereof
02/03/2010CN101637446A Injection containing compound anti-cancer slow release agent
02/03/2010CN101637445A Compound anti-cancer slow release agent
02/03/2010CN101637444A Anti-cancer drug slow release injection containing gemcitabine
02/03/2010CN101637443A Solid preparation containing cysteine with reduced smell
02/03/2010CN101637442A Ranolazine oral sustained-release preparation and preparation method thereof
02/03/2010CN101637441A Moguisteine dried suspension and preparation method thereof
02/03/2010CN100586948C Crystalline anticholinergic, method for its preparation, and use thereof in medicament preparation
02/03/2010CN100586497C Ultrasonic device for wound treatment
02/03/2010CN100586464C Plaster of easing pain, removing swelling, promoting blood flow and removing blood stasis, activating the channels and removing rheumatism and preparation method
02/03/2010CN100586427C Erythromycin enteric-coated capsule and preparation thereof
02/03/2010CN100586426C Capsule of compound glycyrrhzin and preparation method thereof
1 ... 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 ... 2991